Trademarkia Logo

Canada

C$
Trademark Search in Canada
VANTALA

View On IC.GC.CA

VANTALA
ADVERTISED

on 5 Mar 2025

Last Applicant/ Owned by

Kira Biotech Pty Limited

c/o Life Sciences Queensland LtdLevel 3, 88 Jephson StreetToowong QLD 4066

AU

Serial Number

2151253 filed on 22nd Oct 2021

Correspondent Address

GOWLING WLG (CANADA) LLP

1 MAIN STREET WESTHAMILTON

ONTARIO

CA

L8P4Z5

VANTALA

Trademark usage description

pharmaceutical, medicinal, and veterinary preparations for the treatment, management, diagnosis, and prevention of immune system disorders namely mono Read More

Classification Information

Class [005]
Pharmaceutical, medicinal, and veterinary preparations for the treatment, management, diagnosis, and prevention of immune system disorders namely monoclonal antibodies or other biologic molecules; chemicals for pharmaceutical, medicinal, or veterinary use, and preparations comprising the same, for the treatment, management, diagnosis, and prevention of immune system disorders namely monoclonal antibodies or other biologic molecules; pharmaceutical, medicinal, or veterinary drugs, and preparations comprising the same, for the treatment, management, diagnosis, and prevention of immune system disorders; namely monoclonal antibodies or other biologic molecules; immunomodulators and preparations comprising the same, for the treatment, management, diagnosis, and prevention of immune system disorders; antibodies and preparations comprising the same, for the treatment, management, diagnosis, and prevention of immune system disorders; antibodies for pharmaceutical, medicinal, or veterinary use, and preparations comprising the same, for the treatment, management, diagnosis, and prevention of immune system disorders

Classification kind code

11

Class [042]
Scientific research, clinical research and development services of monoclonal antibodies; advisory and consultancy services relating to scientific research, clinical research and development services of monoclonal antibodies; scientific research of monoclonal antibodies; scientific research consultancy of monoclonal antibodies; provision of scientific information in the field of monoclonal antibodies; scientific research and technical analysis in the field of monoclonal antibodies; medical research; pharmaceutical research; research and development of products in the field of monoclonal antibodies; research and development relating to pharmaceuticals, medicines, and drugs; scientific research and development services for pharmaceutical, veterinary, and medical purposes; advisory and consultancy services relating to scientific research and development services for pharmaceutical, veterinary, and medical purposes; scientific research, clinical research and development services in relation to pharmaceutical, medicinal, and veterinary drugs, and preparations comprising the same, for the treatment, management, diagnosis, and prevention of immune system disorders; advisory and consultancy services relating to scientific research, clinical research and development services in relation to pharmaceutical, medicinal, or veterinary drugs, and preparations comprising the same, for the treatment, management, diagnosis, and prevention of immune system disorders

Classification kind code

11

Mark Details

Serial Number

2151253

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 18th Jul 2023		Agent Changed
Submitted for opposition 22
on 17th Feb 2023		Search Recorded
Submitted for opposition 20
on 17th Feb 2023		Examiner's First Report
Submitted for opposition 223
on 17th Feb 2023		Total Provisional Refusal
Submitted for opposition 256
on 3rd Oct 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 2th Dec 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 1st Dec 2021		Formalized
Submitted for opposition 1
on 1st Dec 2021		Created
Submitted for opposition 228
on 22nd Oct 2021		International Registration
Submitted for opposition 30
on 22nd Oct 2021		Filed